Startups & VC

A*STAR, SingHealth spin-off Bioactivx lands US$3M for next-gen wound care

26 sec read0 views0 listens

Singapore-based Bioactivx has raised $3 million to develop its synthetic skin substitute, Bioactiv Matrix, aimed at improving wound care in resource-limited settings. This funding helps the startup expand manufacturing and regulatory capabilities, addressing a critical need for advanced yet practical wound-care solutions in Southeast Asia. Watch for Bioactivx's progress towards regulatory approval and market entry in Singapore by late 2026.

Read the full article at e27

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Real Estate & Home11 hours ago30 sec read

'Hard to find': Tech entrepreneur's beach pad offers privacy, views

Tech entrepreneur Tim Norton is selling his three-bedroom Tamarama apartment with ocean views for $7 million at auction. The sub-penthouse, known for its privacy and high-end finishes by Mim Design, includes Wolf and Sub-Zero appliances and spans 150...

Ali Nemati

Startups & VC1 day ago28 sec read

Why Bootstrapped Businesses Are More Relevant Than Ever

Bootstrapped businesses are gaining relevance as AI reduces the need for substantial initial funding, allowing founders to build and validate products with minimal resources. This shift benefits entrepreneurs who can focus on solving existing custome...

Ali Nemati

Startups & VC1 day ago1m & 6 s read

Ecosystem Roundup: SEA's EV startups pull in US$622M as bets move from pitch to pilot

The article "Ecosystem Roundup: SEA's EV Startups Pull In US$622M As Bets Move From Pitch To Pilot" highlights several key points about the electric vehicle (EV) startup ecosystem in Southeast Asia: Funding for EV Startups: The article mentions tha...

Ali Nemati